A reappraisal of CTLA-4 checkpoint blockade hypothesis in cancer immunotherapy

被引：0
|
作者：
Du, Xuexiang [1 ]
Tang, Fei [1 ]
Liu, Mingyue [1 ]
Zheng, Pan [1 ]
Liu, Yang [1 ]
机构：
[1] Univ Maryland, Sch Med, Div Immunotherapy, Inst Human Virol, Baltimore, MD 21201 USA
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2019年 / 81卷
关键词：
D O I：
10.1097/01.qai.0000558006.23515.a0
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
PC-3
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [1] A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
    Xuexiang Du
    Fei Tang
    Mingyue Liu
    Juanjuan Su
    Yan Zhang
    Wei Wu
    Martin Devenport
    Christopher A Lazarski
    Peng Zhang
    Xu Wang
    Peiying Ye
    Changyu Wang
    Eugene Hwang
    Tinghui Zhu
    Ting Xu
    Pan Zheng
    Yang Liu
    Cell Research, 2018, 28 : 416 - 432
  • [2] A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
    Du, Xuexiang
    Tang, Fei
    Liu, Mingyue
    Su, Juanjuan
    Zhang, Yan
    Wu, Wei
    Devenport, Martin
    Lazarski, Christopher A.
    Zhang, Peng
    Wang, Xu
    Ye, Peiying
    Wang, Changyu
    Hwang, Eugene
    Zhu, Tinghui
    Xu, Ting
    Zheng, Pan
    Liu, Yang
    CELL RESEARCH, 2018, 28 (04) : 416 - 432
  • [3] CTLA-4 blockade and the renaissance of cancer immunotherapy
    Mocellin, Simone
    Nitti, Donato
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1836 (02): : 187 - 196
  • [4] Soluble CTLA-4-A confounding factor in CTLA-4 based checkpoint immunotherapy in cancer
    Azimnasab-sorkhabi, Parviz
    Soltani-asl, Maryam
    Bouhajra, Musab
    Ansa-Addo, Ephraim A.
    Kfoury Junior, Jose Roberto
    IMMUNOLOGY LETTERS, 2025, 272
  • [5] Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy
    Liu, Yang
    Zheng, Pan
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (01) : 4 - 12
  • [6] CTLA-4 blockade-based immunotherapy for prostate cancer.
    Fong, L
    Rini, B
    Kavanaugh, B
    Small, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 185S - 185S
  • [7] PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?
    Tanvetyanon, Tawee
    Gray, Jhanelle E.
    Antonia, Scott J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (03) : 305 - 312
  • [8] Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
    Satoshi Wada
    Christopher M Jackson
    Kiyoshi Yoshimura
    Hung-Rong Yen
    Derese Getnet
    Timothy J Harris
    Monica V Goldberg
    Tullia C Bruno
    Joseph F Grosso
    Nicholas Durham
    George J Netto
    Drew M Pardoll
    Charles G Drake
    Journal of Translational Medicine, 11
  • [9] Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
    Wada, Satoshi
    Jackson, Christopher M.
    Yoshimura, Kiyoshi
    Yen, Hung-Rong
    Getnet, Derese
    Harris, Timothy J.
    Goldberg, Monica V.
    Bruno, Tullia C.
    Grosso, Joseph F.
    Durham, Nicholas
    Netto, George J.
    Pardoll, Drew M.
    Drake, Charles G.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [10] Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
    Vetizou, Marie
    Pitt, Jonathan M.
    Daillere, Romain
    Lepage, Patricia
    Waldschmitt, Nadine
    Flament, Caroline
    Rusakiewicz, Sylvie
    Routy, Bertrand
    Roberti, Maria P.
    Duong, Connie P. M.
    Poirier-Colame, Vichnou
    Roux, Antoine
    Becharef, Sonia
    Formenti, Silvia
    Golden, Encouse
    Cording, Sascha
    Eberl, Gerard
    Schlitzer, Andreas
    Ginhoux, Florent
    Mani, Sridhar
    Yamazaki, Takahiro
    Jacquelot, Nicolas
    Enot, David P.
    Berard, Marion
    Nigou, Jerome
    Opolon, Paule
    Eggermont, Alexander
    Woerther, Paul-Louis
    Chachaty, Elisabeth
    Chaput, Nathalie
    Robert, Caroline
    Mateus, Christina
    Kroemer, Guido
    Raoult, Didier
    Boneca, Ivo Gomperts
    Carbonnel, Franck
    Chamaillard, Mathias
    Zitvogel, Laurence
    SCIENCE, 2015, 350 (6264) : 1079 - +
12345